RCM Technologies (RCMT) Q3 2025 Earnings Call Summary

1Key Financial Results and Metrics

Consolidated Gross Profit: $19.4 million, up 8.8% from Q3 2024.

Adjusted EBITDA: $5.5 million, a slight decline of 1.4% from $5.6 million in Q3 2024.

Adjusted EPS: $0.42, unchanged from the prior year.

Healthcare Segment: Gross profit of $9.0 million (up 8.5%), with school revenue at $24.4 million (up 20.7%). Non-school revenue declined by 11.3%.

Engineering Segment: Gross profit of $6.9 million (up 17.3%), marking the best quarter in history for engineering.

Life Sciences and Data Solutions: Gross profit of $3.5 million, down 4.2% from the previous year.

Excess Medical Costs: Approximately $1.8 million year-to-date, impacting SG&A expenses.

2Strategic Updates and Business Highlights

Record Engineering Backlog: Achieved a backlog of over $70 million for 2026, indicating strong demand in Energy Services.

Healthcare Growth: Continued momentum with new school partnerships and increased penetration in existing clients, despite a slow start in Q3 due to summer session revenue.

Life Sciences Innovations: Partnering with AI-driven companies to enhance compliance and operational efficiency, positioning for growth amid industry shifts.

Energy Services: Strong performance attributed to a focus on Tier 1 utility clients and an integrated engineering and EPC model that has gained traction.

3Forward Guidance and Outlook

Optimistic Q4 Expectations: Anticipating the highest quarterly gross profit and adjusted EBITDA for fiscal 2025.

Healthcare Pipeline: Expecting benefits from a record foreign recruitment pipeline, with 300 nurses ready to come over pending visa approvals.

Long-term Growth: Aiming for continued growth in 2026 across all segments, particularly in healthcare and energy services.

4Bad News, Challenges, or Points of Concern

Excess Medical Costs: Ongoing high medical costs are a significant concern, with no immediate relief expected in Q4.

Cash Flow Issues: Disappointment in cash flow from operations due to administrative collection challenges with large school clients.

Declining Gross Margins: Engineering gross margins decreased year-over-year, attributed to revenue mix and subcontracting costs.

Competitive Pressures: Increased competition in certain markets, particularly in healthcare, though RCM has managed to maintain market share.

5Notable Q&A Insights

Foreign Nurse Recruitment: The timing of foreign nurse arrivals is uncertain due to visa retrogression, but RCM has a strong pipeline ready to deploy.

Medical Cost Predictions: Medical costs are difficult to predict, with inflationary pressures impacting overall expenses.

Industrial Process Segment: While stable, the Industrial Process unit requires strategic adjustments to enhance performance.

Energy Services Market: RCM is focusing on Tier 1 utility clients and exploring selective opportunities in data center projects, maintaining a cautious approach to expansion.

Capital Allocation: RCM is considering share repurchases and potential dividends, with a strong balance sheet providing flexibility. This summary encapsulates the key points from RCM Technologies' Q3 2025 earnings call, highlighting financial performance, strategic initiatives, and challenges faced by the company.